Preprint: Decolonisation of Staphylococcus Aureus and therapeutic test to assist the diagnosis in ME/CFS, Long Covid..., 2023, Chang et al.

DECOLONIZATION OF STAPHYLOCOCCUS AUREUS AND THERAPEUTIC TEST TO ASSIST THE DIAGNOSIS IN ME/CFS, LONG COVID, POST-VACCINE COVID SYNDROME AND OTHER DISEASES WITH FATIGUE AND/OR CHRONIC PAIN.

Preprint

Chang, Figueredo

Abstract
There is a Subgroup of patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID Syndrome or PACS who present a persistent bacterial infection that affects the upper respiratory tract, and especially at the level of the nostrils. We estimate that this Subgroup of patients presenting this persistent infection as a causal or contributing factor would be around a third of all cases. The most frequent causative agent of these persistent and/or recurrent infections is the Staphylococcus aureus bacterium. According to the studies carried out, this bacterium is present in the nasal passages of between 16 and 36% of the general population, who are carriers of Staphylococcus aureus, and are often unaware of it. Among medical care personnel, the percentage of carriers can reach around 40%. ...

https://www.researchgate.net/public...THER_DISEASES_WITH_FATIGUE_ANDOR_CHRONIC_PAIN

 

This is an opinion piece. The authors believe that staphylococcus aureus plays a role in about a third of ME/CFS cases but do not report any data that supports this.

 

From the same authors:

https://www.s4me.info/threads/prepr...usion-2021-chang-figueredo.23785/#post-397157

https://www.s4me.info/threads/me-cf...-persistent-clots-2021-chang-figueredo.23216/